Immunovant
IMVT
IMVT
215 hedge funds and large institutions have $2.75B invested in Immunovant in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 40 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% less capital invested
Capital invested by funds: $2.76B → $2.75B (-$14.3M)
7.63% less ownership
Funds ownership: 61.96% → 54.34% (-7.6%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
215
Holding in Top 10
7
Calls
$61.3M
Puts
$8.52M
Top Buyers
| 1 | +$72.4M | |
| 2 | +$64.6M | |
| 3 | +$39.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$19.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$15M |
Top Sellers
| 1 | -$56.5M | |
| 2 | -$50.8M | |
| 3 | -$37.5M | |
| 4 |
Morgan Stanley
New York
|
-$25.1M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$22.8M |
